RecruitingNCT04535882

Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Showa Inan General Hospital
Intervention
serum leucine-rich alpha-2 glycoprotein (LRG) levels(diagnostic_test)
Enrollment
300 target
Eligibility
All sexes
Timeline
20202026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04535882 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials